http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110141583-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9683e667c2fc35e99047b5a77fea519c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747 |
| filingDate | 2019-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d514cb8dd05296162fc7ed24147f4181 |
| publicationDate | 2019-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110141583-A |
| titleOfInvention | Application of a kind of Lactobacillus kefir M3 in bacteriostasis and as an active ingredient in the treatment of type Ⅱ diabetes |
| abstract | Application of Lactobacillus kefir M3 in bacteriostasis and as an active ingredient of a medicament for treating type II diabetes. The invention solves the problems of low surface hydrophobicity of the existing lactic acid bacteria and poor bacteriostatic ability of the lactic acid bacteria. The Lactobacillus kefiri M3 of the invention has obvious inhibitory effect on Escherichia coli and Staphylococcus aureus, and has good bacteriostatic effect. The Lactobacillus kefiri M3 and the bacterial preparation of the present invention have excellent surface hydrophobicity and cohesion, and have good adhesion to the intestinal tract, so that they have good blood sugar in the application of type II diabetes. Adjustment ability, the Lactobacillus kefiri M3 of the present invention has obvious relieving effect on type II diabetes. |
| priorityDate | 2019-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 146.